Cite
HARVARD Citation
Mair, M. et al. (n.d.). P11.27.B Whole genome DNA methylation as predictive biomarker in CNS WHO grade 2 and 3 oligodendroglioma patients receiving early postoperative treatment. Neuro-oncology. pp. ii62-ii63. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Mair, M. et al. (n.d.). P11.27.B Whole genome DNA methylation as predictive biomarker in CNS WHO grade 2 and 3 oligodendroglioma patients receiving early postoperative treatment. Neuro-oncology. pp. ii62-ii63. [Online].